Clinical trial
Characterization of Patients With Geographic Atrophy (GA) in the US
NCT05891275 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Patients With Geographic Atrophy (GA) in the US
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2023
- Completion date
- December 1, 2023
- Enrollment
- 68,563 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.